Cancer Management & Treatment | Cancer Research & Drug Trials

Top News

Biomarker-Guided First-Line Treatment Improves OS in Advanced NSCLC

Best Outcomes With First-Line Treatment for Unresectable ESCC

Use of Palliative Care in Metastatic Breast Cancer Varies by Race/Ethnicity

Many Oncology Practices Do Not Screen for Caregiver Well-Being

Odronextamab Granted Priority Review for Rel/Ref FL, DLBCL

Nobel Prize Awarded to mRNA Pioneers

Discrimination Motivates Clinical Trial Participation, Survey Suggests

Excellent Adherence to Hormone Therapy Deemed “Critical” for DCIS Patients

Prophylactic Radiation Improves Outcomes in Patients With Metastatic Solid Tumors

Dendritic Cell Vaccine May Improve ASCT Outcomes in Multiple Myeloma

FDA Intends to Increase Oversight of Laboratory-Developed Tests

Insurance Issues With COVID-19 Vaccines Mostly Fixed

EDITORIAL ADVISORY BOARD

Barbara Ann Burtness, MD

Steven Cohen, MD

E. David Crawford, MD

Don S. Dizon, MD, FACP

Jeffrey M. Farma, MD

Neal D. Shore, MD, FACS

Mark A. Socinski, MD

Mario Sznol, MD

Click here for complete profiles

Featured

AI in Oncology: Current and Future Applications

AI has been used in oncology for years, but recent studies suggest AI could have many additional applications in cancer care.
What Happens to Health Programs if the Federal Government Shuts Down?

For the first time since 2019, congressional gridlock is poised to temporarily shut down big parts of the federal government, including many health programs.
New YouTube Policy Targets Cancer Misinformation

Online misinformation is harming cancer patients. YouTube has been part of the problem, but a new policy might change that.
Mississippi’s Cervical Cancer Deaths Indicate Broader Health Care Problems

Mississippi had the nation’s second-highest age-adjusted cervical cancer mortality rate from 2016 through 2020.
Breakthroughs in Targeted Therapy, Immunotherapy Reduce Cancer Deaths

Breakthroughs in targeted therapy and immunotherapy are partly responsible for the recent decline in US cancer deaths, according to the AACR Cancer Progress Report 2023.
WCLC 2023

News from the World Conference on Lung Cancer

More Features

a doctor in his office showing an informed consent document and pointing with a pen where the patient must to sign

The Challenge of Making Cancer Trials More Diverse

By

Alan P. Lyss, MD

Woman with cancer using a laptop, looking stressed

Billing for Patient Portal Messages Reduces Docs’ Workloads but May Increase Financial Toxicity for Cancer Patients

By

Aaron Tallent

Senior man wears N95 face mask.

Mask Mandates Have Kept One Cancer Center Free From COVID-19. Others Have Lifted Masking Requirements Despite Patient Concerns

By

Victoria Forster, PhD

doctor with older woman patient receiving chemotherapy

Medicare Limits Cancer Patients’ Access to Home Infusions. A New Bill Could Change That.

By

Mary Ellen Schneider

With Twitter (Now X) in Flux, Is #MedTwitter Under Threat?

By

Mark L. Fuerst

More Features »

Fact Sheets

Overall, it is estimated that approximately 7% to 11% of patients experience tumor shrinkage in phase 1 trials.

Phase 1 Trials: What to Expect

Managing adverse effects after starting a TKI can be challenging, and health care practitioners ofte

Considering Rehabilitation for Physical or Cognitive Deficits Associated With Cancer